We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.


1.15 (1.12%)
Dec 08 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 458,965
Bid Price 102.25
Ask Price 103.45
News -
Share Name Share Symbol Market Stock Type
BioNTech SE BNTX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
1.15 1.12% 103.07 18:23:14
Open Price Low Price High Price Close Price Previous Close
101.19 100.70 103.62 103.43 101.925
Trades Shares Traded VWAP Financial Volume Average Volume
9,392 458,965  102.64  47,107,121 -
Last Trade Type Quantity Price Currency
18:23:14 1  103.43 USD

BioNTech (BNTX) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


BioNTech SE Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 240.99M - 17.31B 9.43B - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News BioNTech

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No BNTX Message Board. Create One! See More Posts on BNTX Message Board See More Message Board Posts

BNTX Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

BioNTech SE is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |